Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep;75(3):740-742.
doi: 10.1016/j.jhep.2021.04.024. Epub 2021 Apr 24.

Risk stratification in hospitalized COVID-19 patients

Affiliations
Comment

Risk stratification in hospitalized COVID-19 patients

Angela Horvath et al. J Hepatol. 2021 Sep.
No abstract available

Keywords: SARS-Cov-2; liver function abnormality; mortality.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare no conflict of interest. Please refer to the accompanying ICMJE disclosure forms for further details.

Figures

Fig. 1
Fig. 1
Prediction of in-hospital mortality. (A) AUROC for the proposed nomogram and the simplified version. (B) Kaplan-Meier curves according to the simplified nomogram (p <0.0001, Log-rank test).

Comment on

  • Association of liver abnormalities with in-hospital mortality in patients with COVID-19.
    Ding ZY, Li GX, Chen L, Shu C, Song J, Wang W, Wang YW, Chen Q, Jin GN, Liu TT, Liang JN, Zhu P, Zhu W, Li Y, Zhang BH, Feng H, Zhang WG, Yin ZY, Yu WK, Yang Y, Zhang HQ, Tang ZP, Wang H, Hu JB, Liu JH, Yin P, Chen XP, Zhang B; Tongji Multidisciplinary Team for Treating COVID-19 (TTTC). Ding ZY, et al. J Hepatol. 2021 Jun;74(6):1295-1302. doi: 10.1016/j.jhep.2020.12.012. Epub 2020 Dec 19. J Hepatol. 2021. PMID: 33347952 Free PMC article.

References

    1. Ding Z.Y., Li G.X., Chen L., Shu C., Song J., Wang W., et al. Association of liver abnormalities with in-hospital mortality in patients with COVID-19. J Hepatol. 2021 Jun;74(6):1295–1302. - PMC - PubMed
    1. Wang H., Qiu P., Liu J., Wang F., Zhao Q. The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2020;44:653–661. - PMC - PubMed
    1. Kulkarni A.V., Kumar P., Tevethia H.V., Premkumar M., Arab J.P., Candia R., et al. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther. 2020;52:584–599. - PMC - PubMed
    1. Wu Y., Li H., Guo X., Yoshida E.M., Mendez-Sanchez N., Levi Sandri G.B., et al. Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis. Hepatol Int. 2020;14:621–637. - PMC - PubMed
    1. Wu Z.H., Yang D.L. A meta-analysis of the impact of COVID-19 on liver dysfunction. Eur J Med Res. 2020;25:54. - PMC - PubMed

LinkOut - more resources